• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly November 2008

CenterWatch Monthly November 2008

November 4, 2008
CenterWatch Staff

No Standard Policy for Conflicts of Interest

Many research organizations have taken actions to strengthen their policies for managing financial conflicts in recent years. Despite individual organizations’ efforts, there are no universally accepted standards for managing conflicts of interest in clinical research. Nor is there a model policy to aid institutions in the development of their own policies.

Medical Writing Takes Off in India

Medical writing is the latest niche CRO service to be a focus in India. India-based company Cactus Communications has opened an office in the U.S., positioning itself to become a player in Western markets. With an English-speaking, highly skilled workforce and an infrastructure that meets international standards, India can expect to see more niche CRO services outsourced there.

Pediatric Networks Coming Into Their Own

Two years after the European pediatric regulation went into effect, its mandate to create a European pediatric network of research. The need for dedicated pediatric networks is clear. About 20% of the EU population, or about 100 million, are less than 16 years old. Between 50% and 90% of pediatric medicines have not been tested and evaluated. Between 15% and 20% of rare diseases only affect children, and 55% affect both adults and children. A budget of 30 million euros has been dedicated to pediatric research funding for studies into off-patent medicinal products for the first two years of the program.

Eye On: Cardiovascular Diseases

Heart disease is now the number one cause of death among adult women as well as adult men in both the United States and Europe. Acute myocardial infarction (AMI), or heart attack, results from atherosclerotic blockage of the main arteries supplying the heart muscle. AMI is the leading cause of cardiovascular death in the developed world, with more than 2 million new cases each year in the United States, Western Europe and Japan.

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing